university to bring together a high concentration of cellular energetics, metabolism, and mitochondrial expertise. Their platform is enabled by the collaborative effort between the Metabolism Theme, Technology Development Group, and entrepreneurs to transform the university’s research into a robust therapeutic pipeline to spur innovation and collaboration with pharmaceutical partners.

Enspire Bio is currently developing therapeutic programs for fatty liver disease, diabetes and obesity, epilepsy, Parkinson’s, and diseases associated with mitophagy and lysosomal dysfunction.